|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 26702 |
FusionGeneSummary for PEX13_CHMP3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: PEX13_CHMP3 | Fusion gene ID: 26702 | Hgene | Tgene | Gene symbol | PEX13 | CHMP3 | Gene ID | 5194 | 51652 |
| Gene name | peroxisomal biogenesis factor 13 | charged multivesicular body protein 3 | |
| Synonyms | NALD|PBD11A|PBD11B|ZWS | CGI-149|NEDF|VPS24 | |
| Cytomap | 2p15 | 2p11.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | peroxisome biogenesis factor 13peroxin-13peroxisomal membrane protein PEX13 | charged multivesicular body protein 325.1 proteinCHMP family, member 3chromatin-modifying protein 3neuroendocrine differentiation factorvacuolar protein sorting 24 homologvacuolar protein sorting-associated protein 24 | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q92968 | Q9Y3E7 | |
| Ensembl transtripts involved in fusion gene | ENST00000444100, ENST00000401576, ENST00000472678, ENST00000295030, ENST00000414712, | ENST00000263856, ENST00000409727, ENST00000409225, ENST00000439940, ENST00000494623, | |
| Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 3 X 3 X 2=18 |
| # samples | 1 | 3 | |
| ** MAII score | log2(1/1*10)=3.32192809488736 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: PEX13 [Title/Abstract] AND CHMP3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | CHMP3 | GO:0039702 | viral budding via host ESCRT complex | 24878737 |
| Tgene | CHMP3 | GO:0051258 | protein polymerization | 23051622 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | LUSC | TCGA-60-2715-01A | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000444100 | ENST00000263856 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-intron | ENST00000444100 | ENST00000409727 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-intron | ENST00000444100 | ENST00000409225 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-intron | ENST00000444100 | ENST00000439940 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-5UTR | ENST00000444100 | ENST00000494623 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| Frame-shift | ENST00000401576 | ENST00000263856 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-intron | ENST00000401576 | ENST00000409727 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-intron | ENST00000401576 | ENST00000409225 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-intron | ENST00000401576 | ENST00000439940 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-5UTR | ENST00000401576 | ENST00000494623 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 3UTR-3CDS | ENST00000472678 | ENST00000263856 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 3UTR-intron | ENST00000472678 | ENST00000409727 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 3UTR-intron | ENST00000472678 | ENST00000409225 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 3UTR-intron | ENST00000472678 | ENST00000439940 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 3UTR-5UTR | ENST00000472678 | ENST00000494623 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| Frame-shift | ENST00000295030 | ENST00000263856 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-intron | ENST00000295030 | ENST00000409727 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-intron | ENST00000295030 | ENST00000409225 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-intron | ENST00000295030 | ENST00000439940 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-5UTR | ENST00000295030 | ENST00000494623 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| Frame-shift | ENST00000414712 | ENST00000263856 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-intron | ENST00000414712 | ENST00000409727 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-intron | ENST00000414712 | ENST00000409225 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-intron | ENST00000414712 | ENST00000439940 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
| 5CDS-5UTR | ENST00000414712 | ENST00000494623 | PEX13 | chr2 | 61244986 | + | CHMP3 | chr2 | 86737602 | - |
Top |
FusionProtFeatures for PEX13_CHMP3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PEX13 | CHMP3 |
| Component of the peroxisomal translocation machinerywith PEX14 and PEX17. Functions as a docking factor for thepredominantly cytoplasmic PTS1 receptor (PAS10/PEX5). Involved inthe import of PTS1 and PTS2 proteins. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PEX13_CHMP3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PEX13_CHMP3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| PEX13 | PEX5, PEX19, PEX7, PEX14, PEX13, SPRR2A, BTN3A2, C3AR1, TRAF1, LPAR1 | CHMP3 | IGFBP7, STAMBP, CHMP2A, VTA1, VPS4A, VAV2, CHMP4A, CHMP3, CHMP4B, CHMP2B, TNPO3, RAB11A, ATP6V1B1, APP, SMAD1, SMAD5, MEPCE, CXorf56, VAX2, CHMP1B, DAXX, TFG, SIX2, CHMP5 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PEX13_CHMP3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for PEX13_CHMP3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | PEX13 | C1832200 | Peroxisome biogenesis disorders | 3 | CTD_human |
| Hgene | PEX13 | C0043459 | Zellweger Syndrome | 2 | CTD_human;ORPHANET |
| Hgene | PEX13 | C0162309 | Adrenoleukodystrophy | 1 | CTD_human |
| Hgene | PEX13 | C3554001 | PEROXISOME BIOGENESIS DISORDER 11B | 1 | UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|